Movatterモバイル変換

[0]ホーム
URL:

Desmond et al., 2015 - Google Patents

Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment

Desmond et al., 2015

ViewPDF
Document ID
7844997507426221761
Author
Desmond A
Kurian A
Gabree M
Mills M
Anderson M
Kobayashi Y
Horick N
Yang S
Shannon K
Tung N
Ford J
Lincoln S
Ellisen L
Publication year
Publication venue
JAMA oncology

External Links

Snippet

Importance The practice of genetic testing for hereditary breast and/or ovarian cancer (HBOC) is rapidly evolving owing to the recent introduction of multigene panels. While these tests may identify 40% to 50% more individuals with hereditary cancer gene mutations than …
Continue reading atjamanetwork.com (PDF) (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345—Medical expert systems, neural networks or other automated diagnosis
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work
    • G06Q50/24—Patient record management
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/36—Computer-assisted acquisition of medical data, e.g. computerised clinical trials or questionnaires
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01—Social networking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation, e.g. computer aided management of electronic mail or groupware; Time management, e.g. calendars, reminders, meetings or time accounting
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F21/00—Security arrangements for protecting computers, components thereof, programs or data against unauthorised activity
    • G06F21/60—Protecting data
    • G06F21/62—Protecting access to data via a platform, e.g. using keys or access control rules
    • G06F21/6218—Protecting access to data via a platform, e.g. using keys or access control rules to a system of files or objects, e.g. local or distributed file system or database

Similar Documents

PublicationPublication DateTitle
Desmond et al.Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment
Forrest et al.Population-based penetrance of deleterious clinical variants
Hsu et al.Risk of pancreatic cancer among individuals with pathogenic variants in the ATM gene
Fusco et al.Tumor mutation burden and cancer treatment
Graf et al.Comparative effectiveness of immune checkpoint inhibitors vs chemotherapy by tumor mutational burden in metastatic castration-resistant prostate cancer
Torga et al.Patient-paired sample congruence between 2 commercial liquid biopsy tests
Couch et al.Associations between cancer predisposition testing panel genes and breast cancer
Husain et al.Cancer DNA in the circulation: the liquid biopsy
Neidhardt et al.Association between loss-of-function mutations within the FANCM gene and early-onset familial breast cancer
Walter et al.Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma
Agerbo et al.Risk of early-onset depression associated with polygenic liability, parental psychiatric history, and socioeconomic status
Stout et al.Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011
Agarwal et al.Independent validation of effect of HSD3B1 genotype on response to androgen-deprivation therapy in prostate cancer
King et al.Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award
Luryi et al.Treatment factors associated with survival in early-stage oral cavity cancer: analysis of 6830 cases from the National Cancer Data Base
Wunsch et al.Three-year outcomes for Medicare beneficiaries who survive intensive care
Everett et al.Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm
Yoneda et al.Mortality among patients with early-onset atrial fibrillation and rare variants in cardiomyopathy and arrhythmia genes
Byrne et al.Inference in psychiatry via 2-sample mendelian randomization—from association to causal pathway?
Noureldine et al.Evaluation of the effect of diagnostic molecular testing on the surgical decision-making process for patients with thyroid nodules
Wang et al.Association of germline BRCA2 mutations with the risk of pediatric or adolescent non–Hodgkin lymphoma
SehgalHyperprogression in patients with cancer receiving immune checkpoint inhibitors
Schuermeyer et al.Depression, anxiety, and regret before and after testing to estimate uveal melanoma prognosis
Rhee et al.Clonal hematopoiesis and cardiovascular disease in patients with multiple myeloma undergoing hematopoietic cell transplant
Sinicrope et al.Tumor-infiltrating lymphocytes for prognostic stratification in nonmetastatic colon cancer—are we there yet?
[8]ページ先頭
©2009-2025 Movatter.jp